In this study, the decreased m6A level was first detected and high expression of fat mass and obesity-associated protein (FTO) was responsible for the m6A suppression in NPM1-mutated AML. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.